The VC fund, called AB Health Ventures, is looking to invest in early to mid-stage health-related startups both in the U.S. and abroad that focus on innovation in pharmacy and distribution, clinical development and commercialization of pharmaceuticals, and practice solutions for healthcare providers and animal health, according to an April 6 press release.
“I believe that innovation is the catalyst to sustained progress and change, which is why AmerisourceBergen is committed to taking bold, innovative actions to achieve our purpose and drive long-term growth.” said Steve Collis, chairman, president and CEO of AmerisourceBergen.
Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the fund.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
